Business Wire

Hytera Upgrades Communication System for Makkah Metro to Safeguard Hajj in Saudi Arabia

Share

Hytera, the global leading provider of professional communications technologies and solutions, is pleased to announce that the modern Hytera metro communication system specially upgraded for the Makkah Metro is put into operation. This highly integrated and customized system has proven to be helpful in assisting the Makkah Metro to improve the operational efficiency during the busy Hajj season which gathered more than 1 million pilgrims from around the world this year.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220721005468/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Hytera dispatching system in the control center of Makkah Metro (Photo: Business Wire)

The Hajj attracts millions of people each year. The 18-kilometer Makkah Metro that connects the holy sites of Arafat, Muzdalifah and Mina is one of the main means of transportation for those pilgrims. Although the Makkah Metro is only open to the public during the annual Hajj, it is one of the busiest metro routes in the world during this period.

Given that the previous communication system had been running for almost 10 years and became inconvenient and costly to maintain, a replacement of the system was urgently needed. Drawing on its extensive experience in the railway industry, Hytera proposed to the Saudi Railway Company an integrated solution that covers the manufacturing, delivery and installation of the communication system.

“As this year Saudi expected to welcome over 1 million people for the biggest Hajj pilgrimage since the outbreak of the pandemic, the challenge for the transportation system was huge,” said Stanley Song, Deputy General Manager of Hytera Overseas Sales Department. “To ensure a safe Hajj season for pilgrims taking the Makkah Metro, we decided to customize most of the equipment even under a tight schedule.”

The hardware, which includes 5 TETRA base stations and 34 TETRA on-board radios, as well as the combing system and antenna system were all customized to for the optimal performance of the overall system. The tailor-made on-board radios were engineered to connect with the Public Address Systems to enable broadcasting to passengers’ cabin in case of emergencies.

In addition, during Hajj 2022, 2 engineers were assigned by Hytera to work in the operation control center 24/7 consecutively to guarantee safe and smooth running of the system.

Hytera’s involvement in the Hajj was not limited to the Metro. It also provided diversified services to the Ministry of Health, SAUDIA (Saudi Arabian Airlines) at King Abdulaziz International Airport in Jeddah (the gateway to the holy city of Makkah), Saudi National Water Company and other organizations to ensure the success of Hajj 1443.

About Hytera

Hytera Communications Corporation Limited (SZSE: 002583) is a leading global provider of professional communications technologies and solutions. With voice, video and data capabilities, we provide faster, safer, and more versatile connectivity for business and mission critical users. We enable our customers to achieve more in both daily operations and emergency response to make the world more efficient and safer.

Official website: https://bit.ly/3vrYtIP

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

jia.liu@hytera.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions26.4.2024 19:03:00 EEST | Press release

Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions. Of the 20 vendors evaluated, Gartner positioned Kinaxis highest on Ability to Execute, marking the company’s 10th consecutive Leaders Quadrant within the report, a complimentary copy of which can be downloaded here. Kinaxis attributes its position to its patented concurrency approach and a proven track record of delivering innovative solutions against the foundation of its leading vision through the use of advanced technology such as AI, ML, and an intuitive user experience. Bolstered by a rich ecosystem of third-party implementation partners, Kinaxis continues to demonstrate that regardless of a customer’s industry, size, or maturity level, the company can be counted on to seamlessly orchestrate supply chain networks end-to-end from strategic planning to last-mile delivery. The recognitio

Vertex Announces European Commission Approval for KALYDECO® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 18:43:00 EEST | Press release

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)

Suzano 2023 annual report on Form 20-F26.4.2024 18:22:00 EEST | Press release

Suzano S.A. (B3: SUZB3 | NYSE: SUZ) informs that its 2023 Annual Report on Form 20-F was filed today with the U.S. Securities and Exchange Commission. Holders of the Company’s equity securities can receive hard copies of the Annual Report, including its audited financial statements, without charge by request directed to: ri@suzano.com.br. This document is also available on Suzano’s website (http://ir.suzano.com.br/). For further information, please contact our Investor Relations Department: Phone: (+55 11) 3503-9330 E-mail: ri@suzano.com.br View source version on businesswire.com: https://www.businesswire.com/news/home/20240426289818/en/ Contact information Hawthorn Advisors suzano@hawthornadvisors.com

Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer26.4.2024 15:30:00 EEST | Press release

Takeda (TSE:4502/NYSE:TAK) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of fruquintinib, a selective inhibitor of vascular endothelial growth factor receptors (VEGFR) -1, -2 and -3 for the treatment of adult patients with previously treated metastatic colorectal cancer (mCRC). The European Commission (EC) will consider the CHMP positive opinion when determining the potential marketing authorization for fruquintinib for mCRC throughout the European Union (EU), Norway, Liechtenstein and Iceland. If approved, fruquintinib will be the first and only selective inhibitor of all three VEGF receptors approved in the EU for previously treated mCRC.1,2 “People living with metastatic colorectal cancer in the European Union currently have limited treatment options, which can lead to poor outcomes. With this positive opinion for fruquintinib, we are one step closer to potentially offering patients a new

MEDIA ALERT: Wolters Kluwer expert comments on European Parliament vote to pass amendment implementing Basel III reforms26.4.2024 15:00:00 EEST | Press release

The European financial landscape saw a milestone event this week, as the EU Parliament passed the Amendment to Regulation (EU) No 575/2013, implementing the Basel III finalization within Europe. This monumental step forward comes with the adoption of the Capital Requirements Regulation (CRR3) amendments, which are part of a broader legislative package, including amendments to Directive 2013/36/EU, known as the Capital Requirements Directive or CRD. Jeroen Van Doorsselaere, Vice President of Global Product & Platform Management, Wolters Kluwer FRR, said: “The adoption of the Capital Requirements Regulation (CRR3) amendments represents a landmark change for the banking industry, designed to strengthen the framework for risk-based capital requirements and address ESG risks. “This is a major overhaul of the capital requirements framework, impacting various aspects, including credit risk, operational risk, market risk, and the capital floor. Whereas other significant jurisdictions, includin

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye